As Leishmania-infected BMMo AMPK can be activated with AICAR in the absence of SIRT1 (Fig. 6A-B), the treatment with AICAR led to a significantly increase on infection levels, while the concomitant addition of compound c abrogated this infection rise to levels of untreated cells (Fig. 7B). This evidence concerns the gene SIRT1 and infection.